Ginsenoside Rg1 triggers ferroptosis to inhibit hepatocellular carcinoma via SLC7A11 downregulation

Anwei Wei, Zhenzhen Liu, Fei Zhao, Yipu Zhao, Bowei Liu · 2026

Read Ginsenoside Rg1 triggers ferroptosis to inhibit hepatocellular carcinoma via SLC7A11 downregulation by Anwei Wei, Zhenzhen Liu, Fei Zhao, Yipu Zhao, Bowei Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13522317.txt.

Description

Anwei Wei and colleagues show in 2026 that ginsenoside Rg1, a ginseng compound, forces liver cancer cells into ferroptosis, an iron-driven death route that can bypass standard resistance. Liver cancer often presents late, leaving systemic therapy as the main option.

Rg1 slowed growth and migration of liver cancer cells in laboratory tests. Treated cells displayed hallmark ferroptosis features, linking benefit to that death pathway rather than generic toxicity. A cystine transporter called SLC7A11 fell under treatment, restoring ferroptosis sensitivity, although the authors note that its mediator role still needs functional validation. The findings support ferroptosis-targeted combinations for hard-to-treat liver cancer.

Catalog record

CREATORAnwei Wei, Zhenzhen Liu, Fei Zhao, Yipu Zhao, Bowei Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24892
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13522317

Browse the full library · About the Tower of Babel